This is consistent with results from a population-based study utilizing molecular subtype divisions that found that luminal A-like subtypes were associated with the lowest 10-year all-cause mortality of all tumor subtypes, while the HER2-enriched subtype had the highest (18). Here, ERBB2 is linked to neoplasm.